The discovery that this collagen-specific compound was present in urine [4] [5] [6] line (Dpd), identified by mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy [7] , was shown to be formed by the reaction of two hydroxylysine aldehydes with a lysine residue instead of the reaction with hydroxylysine, which results in Pyd formation.
After the development of an HPLC assay for measuring both Pyd and Dpd [8] , a modification involving the use of a prefractionation procedure facilitated quantification of both Pyd and Dpd in urine [9] , a method that was subsequently automated by developing a synthetic internal standard [10] . Based on these procedures, a large number of studies from many different groups has established the utility of the pyridinium crosslinks as markers of collagen degradation [11] [12] [13] [14] . More recently, direct immunoassays of the crosslinks have been developed [15, 16] . In most studies, the close correlation between Pyd and Dpd has indicated that both crosslinks in urine are derived mainly from bone, although changes in the Pyd/Dpd ratios in patients with active rheumatoid arthritis suggest that some Pyd may be derived from other tissues [17] .
Published reference ranges for excretion of the pyridinium crosslinks have varied considerably between groups, particularly for Dpd [14] . Some of the variation between groups may be caused by differences in the standards used in the assays for quantifying the crosslinks. This would not be surprising because different criteria have been used to quantify the standards: Rather than attempt to quantify each crosslink directly [9] , some groups have assumed identical characteristics for both crosslinks as well as equivalence with readily available fluorescent analogs [1, 8] .
The aim of the present study was to establish criteria for the absolute quantification of the Pyd and Dpd that could be used to provide consistent standards for different assays of these markers of bone degradation.
Our strategy was to use the measured absorptivity as the primary standardization criterion for each crosslink, having established purity by mass spectrometry and NMR spectroscopy.
Not only did we take precautions to ensure that each of the isolated crosslinks was converted entirely to the chloride forms, but also, as an additional check on purity, we subjected the isolated compounds to elemental analysis including the chloride anions. were pooled separately and further purified. PURIFICATION 
OF TIlE CROSSLINKS
The isolated crosslink fractions were desalted and purified further by reversed-phasechromatography. After adding heptafluorobutyric acid (final concentration 10 mL/L), the sample was loaded onto a 2.5 x 10 cm preparative C18 column (Preppak cartridge; Waters Chromatography Div., Watford, UK) and fractionated by elution at 4 mL/min with 10 mmoL/L heptafluorobutyric acid in a linear gradient from 150 to 300 mL/L acetonitrile over 30 mm. The crosslink-containing fractions (A295) were pooled and evaporated to dryness under reduced pressure. The yield of purified crosslink from two preparations, each starting with 1 kg of calcified bone, was -56 mg of Pyd and 8 mgofDpd.
To convert the crosslinks entirely to their chloride forms, we separately dissolved in 10 mL of 0.1 molIL HC1 portions containing 5-8 mg of each crosslink and applied each solute to a 0.9 X 5 cm column of phosphocellulose (P11; Whatman, Maidstone, UK) that had been freshly recycled according to the manufacturer's instructions. After the column was washed successively with 10 mL of 0.1 mol/L HCI and 20 mL of 0.2 mollL HCI, the pyridinium crosslink was eluted with 10 mL of 0.5 mol/L HCI, and the solvent was evaporated under reduced pressure. The purified crosslink was finally chromatographed on a 1.3 X 95 crncolumn of Sephadex GlO with 50 mmolfL HC1, and l.5-mL fractions were collected.
Fractions containing the crosslinks, detected by absorbance at 295 nm, were pooled and lyophilized.
ELEMENTAL ANALYSIS
All elemental analyses were performed by Butterworth
Labs.
(Teddington, UK), who provided preweighed crucibles for 
Results

PURITY OF THE ISOLATED COMPOUNDS
The NMR spectra recorded for purified Pyd and Dpd are shown in Fig. 1 . In addition to the chemical shift data, 2-D protonproton homonuclear coupling was performed at 500 MHz; this information was used to determine the peak assignments shown in the legend to Fig. 1 . The structure and peak assignments confirm previous literature [1, 7] reporting NMR of Pyd and Dpd at lower magnetic strengths.
The high-resolution mass spectra for the crosslinks showed in each case the naturally occurring cation as the major species, with measured molecular masses of 429.37 and 413.34 Da for Pyd and Dpd, respectively. These values were within 0.04% of the calculated masses.
The absorbance and fluorescence spectra of each crosslink in 0.1 mol/L HCI or 50 mmol/L sodium phosphate, pH 7.5, are shown in Fig. 2 . Amino acid analysis profiles of purified Pyd and Dpd in comparison with a buffer blank (Fig. 3) 23.86 standards in both acid and neutral solution are given in Table 1 . The positions of selected amino acids are shown. [14] .
After the initial characterization of Pyd, Fujimoto based quantification on the absorptivity of N-methylpyridoxine and the reaction with 2,4,6-trinitrobenzenesulfonic acid [20] . as the model standard compound but further assumed that the molar absorptivities of both Pyd (which they designated HP) and Dpd (LP) were the same [8] .
Our previous studies, based on gravimetric analysis of isolated compounds, indicated that Pyd and Dpd exhibited differences in quantification by fluorescence [9] . More recently, several preparative procedures for isolating larger quantities of the Dpd.
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crosslinks have been described [21, 22] but without addressing the question of absolute standardization. Although most chromatographic assays for the crosslinks use these compounds' natural fluorescence for quantification, temperature dependence [9] , variation between instruments, and sensitivity of free pyridinium compounds to prolonged ultraviolet irradiation [23, 24] make this a poor basis for primary standardization.
Ultraviolet spectroscopy provides a more suitable quantification, so we obtained data on the absorptivities of the compounds at 295 nm in acid and at 325 nm at neutral pH. Although photolysis of the pyridinium crosslinks can occur during fluorescence measurements, the much lower intensity of light sources used for ultraviolet spectroscopy ensures that losses of crosslinks during absorbance monitoring are negligible. e for Pyd in 0.1 mol/L HCI (5490 L moY1 cm') was much lower than the values for N-substituted 3-hydroxypyridinium compounds, which are generally in the 8000-8500 range [25] but can be affected markedly by substituents in the ring [19] . The #{128} values we obtained are based on gravimetric analysis of highly purified samples that had been converted to their monochloride trihydrochloride salts and gave no evidence by mass spectrometry and NMR of substantial impurities. The absorptivity of Dpd was 6-8% lower than that of Pyd in both acid and neutral solution. For both crosslinks, the ratio between the absorbance at 295 nm in acid and at 325 nm at neutral pH may be used as an indication of purity, given that contaminants are unlikely to undergo the same absorbance shift with pH. The A,95/A35 ratios for Pyd and Dpd were 0.950 and 0.975, respectively. Standardization of the pyridinium crosslinks combined with some knowledge of the mean crosslink concentrations in bone allows expression of bone resorption in terms of bone collagen equivalent or as absolute amounts of bone [26, 27] . In recent years, several assays have been developed to measure telopeptide fragments of collagen type I [28, 29] and have been applied clinically as urinary markers of primarily bone degradation. It would be useful to be able to make direct comparisons between the different forms of bone resorption assay. For the telopeptide assays, the pyridinium compounds need not be present for reactivity, and the crosslinks cannot therefore be used to quantify the amount of bone resorbed. The concept of bone collagen equivalents provides some measure of comparison [30] , but the lack of knowledge about the precise nature of the analytes measured in urine by the telopeptide assays confounds any direct comparison between the methods.
In conclusion, this study provides analytical criteria for standardization of the pyridinium crosslinks for use as bone resorption markers. A facility for direct comparison of clinical data between centers is important for the establishment of more clearly defined reference ranges.
